Key facts
- This page summarizes Daniel Woolson's Form 4 filing for ICU MEDICAL INC/DE (ICUI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Mar 2024, 16:49.
Daniel Woolson - 15 Mar 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)
- Reporting relationship
- VP, GM-Infusion Capital
- Issuer ticker
- ICUI
- Reported as of
- 15 Mar 2024
- Net transaction value
- -$126,916
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2024, 16:49:09 UTC
- Prior SEC filing
- 11 Mar 2024
- Next SEC filing
- 30 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel Woolson filed Form 4 for ICU MEDICAL INC/DE (ICUI) on 18 Mar 2024.
Change
- Previous filing in this sequence was filed on 11 Mar 2024.
- Current net transaction value: -$126,916.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ICUI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,923
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 16,903
- Date
- 15 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
ICUI
transaction
Common Stock
Tax liability
- Transaction value
- $126,916
- Shares
- -1,294
- Change %
- -7.7%
- Price
- $98.08
- Shares after
- 15,609
- Date
- 15 Mar 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ICUI
transaction
Derivative
Performance Shares
Options Exercise
- Transaction value
- $0
- Shares
- -2,923
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 5,847
- Date
- 15 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,923
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These Securities are Performance-based Restricted Stock Units (PRSU).
Footnote F2
There is neither a purchase price nor an exercise price for the PRSUs.
Footnote F3
One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date.